Target (CBDY) Retained Earnings (2013 - 2026)
Target (CBDY) reported Retained Earnings of -$32.9 million for Q1 2026, down 4077.56% year-over-year from $826055.2 in Q1 2025, and down 3254.93% quarter-over-quarter from -$979361.0 in Q4 2025.
Target (CBDY) Retained Earnings (2013 - 2026) Analysis & Trends
Target (CBDY) has 14 years of Retained Earnings data on file, last reported at -$32.9 million in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$32.9 million, down 4077.56% year-over-year; the trailing twelve-month figure through Mar 2026 was -$32.9 million (down 4077.56% YoY), and the FY2025 annual result was -$979361.0, up 96.84% from the prior year.
- Retained Earnings eased to -$32.9 million in Q1 2026 per CBDY's latest filing, from -$979361.0 in the prior quarter.
- Over five years, Retained Earnings peaked at -$786508.0 in Q1 2025 and troughed at -$32.9 million in Q1 2026.
- A 5-year average of -$13.2 million and a median of -$1.1 million in 2022 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2025 and 2026: Retained Earnings jumped 97.1% in 2025, then tumbled 4077.56% in 2026.
- A 5-year view of Retained Earnings shows it stood at -$998829.0 in 2022, then fell by 8.96% to -$1.1 million in 2023, then sank by 2743.63% to -$30.9 million in 2024, then surged by 96.84% to -$979361.0 in 2025, then sank by 3254.93% to -$32.9 million in 2026.
- Business Quant data shows CBDY's Retained Earnings at -$32.9 million in Q1 2026, -$979361.0 in Q4 2025, and -$902259.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -4.41 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -1.87 Mn |
| 10 | Target | - | - | 191,787.00 | -32.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.86 Mn |
| Dec 31, 2025 | -979,361.00 |
| Sep 30, 2025 | -902,259.00 |
| Jun 30, 2025 | -978,570.00 |
| Mar 31, 2025 | -786,508.00 |
| Dec 31, 2024 | -30.95 Mn |
| Sep 30, 2024 | -31.16 Mn |
| Jun 30, 2024 | -30.63 Mn |
| Mar 31, 2024 | -995,061.00 |
| Dec 31, 2023 | -1.09 Mn |
| Sep 30, 2023 | -30.92 Mn |
| Jun 30, 2023 | -30.57 Mn |
| Mar 31, 2023 | -1.00 Mn |
| Dec 31, 2022 | -998,829.00 |
| Sep 30, 2022 | -26.86 Mn |
| Jun 30, 2022 | -1.13 Mn |
| Mar 31, 2022 | -1.10 Mn |
| Dec 31, 2021 | -1.11 Mn |
| Sep 30, 2021 | -1.12 Mn |
| Jun 30, 2021 | -28.40 Mn |